Drug combo heralds major shift in chronic lymphocytic leukaemia treatment
A combination of two drugs keeps patients with chronic lymphocytic leukaemia disease-free and alive longer…
Browsing: ibrutinib
Study reports ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia (CLL), have been shown…
Finding second hits to knock out leukaemia
Many new anti-cancer drugs inhibit proteins that are essential for the proliferation of cancer cells.…
New leukaemia drug is more effective and easier to use
A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted…
ASH 2018: Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukaemia
A new study presented at ASH 2018 shows older patients with chronic lymphocytic leukaemia (CLL) have a…
New drugs are improving survival times for patients with aggressive type of blood cancer
Survival times for a highly aggressive type of blood cancer have nearly doubled over the…
PBS listing makes lifesaving cancer drug affordable for sufferers
Sean Parnell, The Australian Patients with leukemia and lymphoma will no longer have to pay…
CAR T-cell therapy for leukaemia leads to remissions in clinical trial
Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common…